NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • A/PROF Eugene Maraskovsky
    • CHEN Q
    • GREEN S
    • SJOLANDER A
    • PEARSE M
    • LEMONNIER FA
    • CHEN W
    • CEBON J
    • SUHRBIER A
    • SJOLANDER S
    • DRANE DP
    • SCHNURR M
    • LE TTT
    • MATEO L
    • LUFT T
    • MASTERMAN KA
    • TAI T

Published in

  • Clinical Cancer Research

Time

Date/time value

  • 2004

Identity

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-03-0245

Additional Document Info

Parent Title

  • Clinical Cancer Research

Volume

  • 10

Issue

  • april 15

Publisher

  • American Association for Cancer Research